Gut bacteria and hydrogen sulfide: The new old players in circulatory system homeostasis

Molecules

Volumn 21, Issue 11, 2016, Pages

  Tomasova, Lenka ^a,b   Konopelski, Piotr ^a   Ufnal, Marcin ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Cardiovascular diseases; Gut bacteria; Hydrogen sulfide; Hypertension; Indole; Microbiota; Sulfur; TMAO

Indexed keywords

HYDROGEN SULFIDE;

ANIMAL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; GASTROINTESTINAL TRACT; HOMEOSTASIS; INTESTINE FLORA; METABOLIC DISORDER; METABOLISM; MICROBIOLOGY; PATHOPHYSIOLOGY;

ANIMALS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HOMEOSTASIS; HYDROGEN SULFIDE; METABOLIC DISEASES;

EID: 84997783056     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules21111558     Document Type: Review

References (165)

1. Kelly, C.R.; Kahn, S.; Kashyap, P.; Laine, L.; Rubin, D.; Atreja, A.; Moore, T.; Wu, G. Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook. Gastroenterology 2015, 149, 223-237.
2. Gaci, N.; Borrel, G.; Tottey, W.; O'Toole, P.W.; Brugere, J.F. Archaea and the human gut: New beginning of an old story. World J. Gastroenterol. 2014, 20, 16062-16078.
3. Honour, J.W. Historical perspective: Gut dysbiosis and hypertension. Physiol. Genomics. 2015, 47, 443-446.
4. John, G.K.; Mullin, G.E. The Gut Microbiome and Obesity. Curr. Oncol. Rep. 2016, 18, 45.
5. Mell, B.; Jala, V.R.; Mathew, A.V.; Byun, J.; Waghulde, H.; Zhang, Y.; Haribabu, B.; Vijay-Kumar, M.; Pennathur, S.; Joe, B. Evidence for a link between gut microbiota and hypertension in the Dahl rat. Physiol. Genom. 2015, 47, 187-197.
6. Parekh, P.J.; Balart, L.A. Ammonia and Its Role in the Pathogenesis of Hepatic Encephalopathy. Clin. Liver Dis. 2015, 19, 529-537.
7. Zhang, Y.J.; Li, S.; Gan, R.Y.; Zhou, T.; Xu, D.P.; Li, H.B. Impacts of Gut Bacteria on Human Health and Diseases. Int. J. Mol. Sci. 2015, 16, 7493-7519.
8. Wang, J.; Qin, J.; Li, Y.; Cai, Z.; Li, S.; Zhu, J.; Zhang, F.; Liang, S.; Zhang, W.; Guan, Y.; et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012, 490, 55-60.
9. Cammarota, G.; Ianiro, G.; Bibbò, S.; Gasbarrini, A. Fecal microbiota transplantation a new old kid on the block for the management of gut microbiota-related disease. J. Clin. Gastroenterol. 2014, 48, S80-S84.
10. Parekh, P.J.; Arusi, E.; Vinik, A.I.; Johnson, D.A. The role and influence of gut microbiota in pathogenesis and management of obesity and metabolic syndrome. Front. Endocrinol. (Lausanne) 2014, 5.
11. Tomasova, L.; Jurkowska, H.; Wrobel, M.; Huc, T.; Ondrias, K.; Ostaszewski, R.; Ufnal, M. Intracolonic hydrogen sulfide lowers blood pressure in rats. Nitric Oxide 2016, 60, 50-58.
12. Shen, X.; Carlstrom, M.; Borniquel, S.; Jadert, C.; Kevil, C.G.; Lundberg, J.O. Microbial regulation of host hydrogen sulfide bioavailability and metabolism. Free Radic. Biol. Med. 2013, 60, 195-200.
13. Raiswell, R.; Canfield, D.E. The iron biogeochemical cycle past and present. Geochem. Perspect. 2012, 1, 1-232.
14. Schopf, J.W. Geological evidence of oxygenic photosynthesis and the biotic response to the 2400-2200 Ma "great Oxidation Event". Biochemistry (Mosc.) 2014, 79, 165-177.
15. Olson, K.R.; Straub, K.D. The role of hydrogen sulfide in evolution and the evolution of hydrogen sulfide in metabolism and signaling. Physiology (Bethesda) 2016, 31, 60-72.
16. Parker, E.T.; Cleaves, H.J.; Callahan, M.P.; Dworkin, J.P.; Glavin, D.P.; Lazcano, A.; Bada, J.L. Prebiotic Synthesis of Methionine and Other Sulfur-Containing Organic Compounds on the Primitive Earth: A Contemporary Reassessment Based on an Unpublished 1958 Stanley Miller Experiment. Orig. Life Evol. Biosph. 2011, 41, 201-212.
17. Parker, E.T.; Cleaves, H.J.; Dworkin, J.P.; Glavin, D.P.; Callahan, M.; Aubrey, A.; Lazcano, A.; Bada, J.L. Primordial synthesis of amines and amino acids in a 1958 Miller H 2S-rich spark discharge experiment. Proc. Natl. Acad. Sci. USA 2011, 108, 5526-5531.
18. Wacey, D.; Kilburn, M.R.; Saunders, M.; Cliff, J.; Brasier, M.D. Microfossils of sulphur-metabolizing cells in 3.4-billion-year-old rocks of Western Australia. Nat. Geosci. 2011, 4, 698-702.
19. Rabus, R.; Venceslau, S.S.; Wöhlbrand, L.; Voordouw, G.; Wall, J.D.; Pereira, I.A.C. A Post-Genomic View of the Ecophysiology, Catabolism and Biotechnological Relevance of Sulphate-Reducing Prokaryotes. Adv. Microb. Physiol. 2015, 66, 55-321.
20. Abe, K.; Kimura, H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J. Neurosci. 1996, 16, 1066-1071.
21. V3 and RyR2 channels. Nitric Oxide 2015, 46, 131-144.
22. 2S on rat blood pressure and inhibits H(2)S-induced nitric oxide release from S-nitrosoglutathione. Physiol. Res. 2014, 64, 479-486.
23. Lohninger, L.; Tomasova, L.; Praschberger, M.; Hintersteininger, M.; Erker, T.; Gmeiner, B.M.; Laggner, H. Hydrogen sulphide induces HIF-1alpha and Nrf2 in THP-1 macrophages. Biochimie 2015, 112, 187-195.
24. Polhemus, D.J.; Lefer, D.J. Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease. Circ. Res. 2014, 114, 730-737.
25. Sikora, M.; Pham, K.; Ufnal, M. Hypotensive effect of S-adenosyl-L-methionine in hypertensive rats is reduced by autonomic ganglia and KATP channel blockers. Amino Acids 2016, 48, 1581-1590.
26. Dombkowski, R.A.; Russell, M.J.; Olson, K.R. Hydrogen sulfide as an endogenous regulator of vascular smooth muscle tone in trout. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 286, R678-R685.
27. Wallace, J.L. Physiological and pathophysiological roles of hydrogen sulfide in the gastrointestinal tract. Antioxid. Redox Signal. 2010, 12, 1125-1133.
28. Yatsunenko, T.; Rey, F.E.; Manary, M.J.; Trehan, I.; Dominguez-Bello, M.G.; Contreras, M.; Magris, M.; Hidalgo, G.; Baldassano, R.N.; Anokhin, A.P.; et al. Human gut microbiome viewed across age and geography. Nature 2012, 486, 222-227.
29. David, L.A.; Maurice, C.F.; Carmody, R.N.; Gootenberg, D.B.; Button, J.E.; Wolfe, B.E.; Ling, A.V.; Devlin, A.S.; Varma, Y.; Fischbach, M.A.; et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014, 505, 559-563.
30. Dominguez-Bello, M.G.; Costello, E.K.; Contreras, M.; Magris, M.; Hidalgo, G.; Fierer, N.; Knight, R. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. USA 2010, 107, 11971-11975.
31. Liu, Z.; Roy, N.C.; Guo, Y.; Jia, H.; Ryan, L.; Samuelsson, L.; Thomas, A.; Plowman, J.; Clerens, S.; Day, L.; Young, W. Human breast milk and infant formulas differentially modify the intestinal microbiota in human infants and host physiology in rats. J. Nutr. 2016, 146, 191-199.
32. Hermann-Bank, M.L.; Skovgaard, K.; Stockmarr, A.; Larsen, N.; Mølbak, L. The Gut Microbiotassay: A high-throughput qPCR approach combinable with next generation sequencing to study gut microbial diversity. BMC Genom. 2013, 14.
33. Donia, M.S.; Fischbach, M.A. Small molecules from the human microbiota. Science 2015, 349, 1254766.
34. Verbeke, K.A.; Boobis, A.R.; Chiodini, A.; Edwards, C.A.; Franck, A.; Kleerebezem, M.; Nauta, A.; Raes, J.; Van Tol, E.A.F.; Tuohy, K.M. Towards microbial fermentation metabolites as markers for health benefits of prebiotics. Nutr. Res. Rev. 2015, 28, 42-66.
35. Lam, V.; Su, J.; Hsu, A.; Gross, G.J.; Salzman, N.H.; Baker, J.E. Intestinal Microbial Metabolites Are Linked to Severity of Myocardial Infarction in Rats. PLoS ONE 2016, 11, e0160840.
36. Oleskin, A.V.; Shenderov, B.A. Neuromodulatory effects and targets of the SCFAs and gasotransmitters produced by the human symbiotic microbiota. Microb. Ecol. Health Dis. 2016, 27, 30971.
37. Ufnal, M. Essential hypertension-is erroneous receptor output to blame? Med. Hypotheses 2012, 78, 454-458.
38. Hansen, M.K.; Krueger, J.M. Subdiaphragmatic vagotomy blocks the sleep- and fever-promoting effects of interleukin-1beta. Am. J. Physiol. 1997, 273, R1246-R1253.
39. Huc, T.; Pham, K.; Skrzypecki, J.; Ufnal, M. Significance of gut-blood barrier in health and disease. Eur. J. Biol. Res. 2016, 6, 193-200.
40. Bischoff, S.C.; Barbara, G.; Buurman, W.; Ockhuizen, T.; Schulzke, J.D.; Serino, M.; Tilg, H.; Watson, A.; Wells, J.M. Intestinal permeability - A new target for disease prevention and therapy. BMC Gastroenterol. 2014, 14, 189.
41. Lekawanvijit, S. Role of gut-derived protein-bound uremic toxins in cardiorenal syndrome and potential treatment modalities. Circ. J. 2015, 79, 2088-2097.
42. Ufnal, M.; Zadlo, A.; Ostaszewski, R. TMAO: A small molecule of great expectations. Nutrition 2015, 31, 1317-1323.
43. Lopetuso, L.R.; Scaldaferri, F.; Bruno, G.; Petito, V.; Franceschi, F.; Gasbarrini, A. The therapeutic management of gut barrier leaking: The emerging role for mucosal barrier protectors. Eur. Rev. Med. Pharmacol. Sci. 2015, 19, 1068-1076.
44. Perrier, C.; Corthesy, B. Gut permeability and food allergies. Clin. Exp. Allergy 2011, 41, 20-28.
45. Sandek, A.; Swidsinski, A.; Schroedl, W.; Watson, A.; Valentova, M.; Herrmann, R.; Scherbakov, N.; Cramer, L.; Rauchhaus, M.; Grosse-Herrenthey, A.; et al. Intestinal blood flow in patients with chronic heart failure: A link with bacterial growth, gastrointestinal symptoms, and cachexia. J. Am. Coll. Cardiol. 2014, 64, 1092-1102.
46. Sandek, A.; Bjarnason, I.; Volk, H.D.; Crane, R.; Meddings, J.B.; Niebauer, J.; Kalra, P.R.; Buhner, S.; Herrmann, R.; Springer, J.; et al. Studies on bacterial endotoxin and intestinal absorption function in patients with chronic heart failure. Int. J. Cardiol. 2012, 157, 80-85.
47. Sandek, A.; Bauditz, J.; Swidsinski, A.; Buhner, S.; Weber-Eibel, J.; von Haehling, S.; Schroedl, W.; Karhausen, T.; Doehner, W.; Rauchhaus, M.; et al. Altered Intestinal Function in Patients With Chronic Heart Failure. J. Am. Coll. Cardiol. 2007, 50, 1561-1569.
48. Arutyunov, G.P.; Kostyukevich, O.I.; Serov, R.A.; Rylova, N.V.; Bylova, N.A. Collagen accumulation and dysfunctional mucosal barrier of the small intestine in patients with chronic heart failure. Int. J. Cardiol. 2008, 125, 240-245.
49. Niebauer, J.; Volk, H.D.; Kemp, M.; Dominguez, M.; Schumann, R.R.; Rauchhaus, M.; Poole-Wilson, P.A.; Andrew, J.; Coats, S.; Anker, S.D. Endotoxin and immune activation in chronic heart failure: A prospective cohort study. Lancet 1999, 353, 1838-1842.
50. Yang, T.; Santisteban, M.M.; Rodriguez, V.; Li, E.; Ahmari, N.; Carvajal, J.M.; Zadeh, M.; Gong, M.; Qi, Y.; Zubcevic, J.; Sahay, B.; et al. Gut dysbiosis is linked to hypertension. Hypertension 2015, 65, 1331-1340.
51. Durgan, D.J.; Ganesh, B.P.; Cope, J.L.; Ajami, N.J.; Phillips, S.C.; Petrosino, J.F.; Hollister, E.B.; Bryan, R.M. Role of the Gut Microbiome in Obstructive Sleep Apnea-Induced Hypertension. Hypertension 2016, 67, 469-474.
52. Murri, M.; Leiva, I.; Gomez-Zumaquero, J.M.; Tinahones, F.J.; Cardona, F.; Soriguer, F.; Queipo-Ortuño, M.I. Gut microbiota in children with type 1 diabetes differs from that in healthy children: A case-control study. BMC Med. 2013, 11.
53. Wallace, J.G.; Gohir, W.; Sloboda, D.M. The impact of early life gut colonization on metabolic and obesogenic outcomes: What have animal models shown us? J. Dev. Orig. Health Dis. 2016, 7, 15-24.
54. Armougom, F.; Henry, M.; Vialettes, B.; Raccah, D.; Raoult, D. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients. PLoS ONE 2009, 4, e7125.
55. Ley, R.E.; Turnbaugh, P.J.; Klein, S.; Gordon, J.I. Microbial ecology: Human gut microbes associated with obesity. Nature 2006, 444, 1022-1023.
56. Murphy, E.F.; Cotter, P.D.; Healy, S.; Marques, T.M.; O'Sullivan, O.; Fouhy, F.; Clarke, S.F.; O'Toole, P.W.; Quigley, E.M.; Stanton, C.; et al. Composition and energy harvesting capacity of the gut microbiota: Relationship to diet, obesity and time in mouse models. Gut 2010, 59, 1635-1642.
57. Duncan, S.H.; Lobley, G.E.; Holtrop, G.; Ince, J.; Johnstone, A.M.; Louis, P.; Flint, H.J. Human colonic microbiota associated with diet, obesity and weight loss. Int. J. Obes. (Lond.) 2008, 32, 1720-1724.
58. Schwiertz, A.; Taras, D.; Schäfer, K.; Beijer, S.; Bos, N.A.; Donus, C.; Hardt, P.D. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 2010, 18, 190-195.
59. Jumpertz, R.; Le, D.S.; Turnbaugh, P.J.; Trinidad, C.; Bogardus, C.; Gordon, J.I.; Krakoff, J. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am. J. Clin. Nutr. 2011, 94, 58-65.
60. Bäckhed, F.; Manchester, J.K.; Semenkovich, C.F.; Gordon, J.I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl. Acad. Sci. USA 2007, 104, 979-984.
61. Bäckhed, F.; Ding, H.; Wang, T.; Hooper, L.V.; Gou, Y.K.; Nagy, A.; Semenkovich, C.F.; Gordon, J.I. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA 2004, 101, 15718-15723.
62. Vijay-Kumar, M.; Aitken, J.D.; Carvalho, F.A.; Cullender, T.C.; Mwangi, S.; Srinivasan, S.; Sitaraman, S.V.; Knight, R.; Ley, R.E.; Gewirtz, A.T. Metabolie syndrome and altered gut microbiota in mice lacking toll-like receptor 5. Science 2010, 328, 228-231.
63. Boros, M.; Ghyczy, M.; Irces, D.; Varga, G.; Tokés, T.; Kupai, K.; Torday, C.; Kaszaki, J. The anti-inflammatory effects of methane. Crit. Care Med. 2012, 40, 1269-1278.
64. Triantafyllou, K.; Chang, C.; Pimentel, M. Methanogens, methane and gastrointestinal motility. J. Neurogastroenterol. Motil. 2014, 20, 31-40.
65. Carbonero, F.; Benefiel, A.C.; Gaskins, H.R. Contributions of the microbial hydrogen economy to colonic homeostasis. Nat. Rev. Gastroenterol. Hepatol. 2012, 9, 504-518.
66. Rey, F.E.; Gonzalez, M.D.; Cheng, J.; Wu, M.; Ahern, P.P.; Gordon, J.I. Metabolic niche of a prominent sulfate-reducing human gut bacterium. Proc. Natl. Acad. Sci. USA 2013, 110, 13582-13587.
67. Gibson, G.R.; Macfarlane, G.T.; Cummings, J.H. Occurrence of sulphate-reducing bacteria in human faeces and the relationship of dissimilatory sulphate reduction to methanogenesis in the large gut. J. Appl. Bacteriol. 1988, 65, 103-111.
68. Croix, J.A.; Carbonero, F.; Nava, G.M.; Russell, M.; Greenberg, E.; Gaskins, H.R. On the relationship between sialomucin and sulfomucin expression and hydrogenotrophic microbes in the human colonic mucosa. PLoS ONE 2011, 6, e24447.
69. Awano, N.; Wada, M.; Mori, H.; Nakamori, S.; Takagi, H. Identification and functional analysis of Escherichia coli cysteine desulfhydrases. Appl. Environ. Microbiol. 2005, 71, 4149-4152.
70. Kumagai, H.; Sejima, S.; Choi, Y.J.; Tanaka, H.; Yamada, H. Crystallization and properties of cysteine desulfhydrase from Aerobacter aerogenes. FEBS Lett. 1975, 52, 304-307.
71. Blachier, F.; Davila, A.M.; Mimoun, S.; Benetti, P.H.; Atanasiu, C.; Andriamihaja, M.; Benamouzig, R.; Bouillaud, F.; Tomé, D. Luminal sulfide and large intestine mucosa: Friend or foe? Amino Acids 2010, 39, 335-347.
72. Siegel, L.M.; Murphy, M.J.; Kamin, H. Reduced nicotinamide adenine dinucleotide phosphate-sulfite reductase of enterobacteria. I. The Escherichia coli hemoflavoprotein: Molecular parameters and prosthetic groups. J. Biol. Chem. 1973, 248, 251-264.
73. Cao, Q.; Zhang, L.; Yang, G.; Xu, C.; Wang, R. Butyrate-stimulated H2S production in colon cancer cells. Antioxid. Redox Signal. 2010, 12, 1101-1109.
74. Distrutti, E.; Sediari, L.; Mencarelli, A.; Renga, B.; Orlandi, S.; Russo, G.; Caliendo, G.; Santagada, V.; Cirino, G.; Wallace, J.L.; et al. 5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity. J. Pharmacol. Exp. Ther. 2006, 319, 447-458.
75. Martin, G.R.; McKnight, G.W.; Dicay, M.S.; Coffin, C.S.; Ferraz, J.G.P.; Wallace, J.L. Hydrogen sulphide synthesis in the rat and mouse gastrointestinal tract. Dig. Liver Dis 2010, 42, 103-109.
76. Wallace, J.L.; Vong, L.; McKnight, W.; Dicay, M.; Martin, G.R. Endogenous and Exogenous Hydrogen Sulfide Promotes Resolution of Colitis in Rats. Gastroenterology 2009, 137, 569-578.
77. Fiorucci, S.; Antonelli, E.; Distrutti, E.; Rizzo, G.; Mencarelli, A.; Orlandi, S.; Zanardo, R.; Renga, B.; Di Sante, M.; Morelli, A.; et al. Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs. Gastroenterology 2005, 129, 1210-1224.
78. Magee, E.A.; Richardson, C.J.; Hughes, R.; Cummings, J.H. Contribution of dietary protein to sulfide production in the large intestine: An in vitro and a controlled feeding study in humans. Am. J. Clin. Nutr. 2000, 72, 1488-1494.
79. Levitt, M.D.; Springfield, J.; Furne, J.; Koenig, T.; Suarez, F.L. Physiology of sulfide in the rat colon: Use of bismuth to assess colonic sulfide production. J. Appl. Physiol. (1985) 2002, 92, 1655-1660.
80. Deplancke, B.; Finster, K.; Graham, W.V.; Collier, C.T.; Thurmond, J.E.; Gaskins, H.R. Gastrointestinal and microbial responses to sulfate-supplemented drinking water in mice. Exp. Biol. Med. (Maywood) 2003, 228, 424-433.
81. Jørgensen, J.; Mortensen, P.B. Hydrogen sulfide and colonic epithelial metabolism: Implications for ulcerative colitis. Dig. Dis. Sci. 2001, 46, 1722-1732.
82. Furne, J.; Springfield, J.; Koenig, T.; DeMaster, E.; Levitt, M.D. Oxidation of hydrogen sulfide and methanethiol to thiosulfate by rat tissues: A specialized function of the colonic mucosa. Biochem. Pharmacol. 2001, 62, 255-259.
83. Levitt, M.D.; Furne, J.; Springfield, J.; Suarez, F.; DeMaster, E. Detoxification of hydrogen sulfide and methanethiol in the cecal mucosa. J. Clin. Investig. 1999, 104, 1107-1114.
84. Flannigan, K.L.; McCoy, K.D.; Wallace, J.L. Eukaryotic and prokaryotic contributions to colonic hydrogen sulfide synthesis. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 301, G188-G193.
85. Roediger, W.E.W.; Duncan, A.; Kapaniris, O.; Millard, S. Sulphide impairment of substrate oxidation in rat colonocytes: A biochemical basis for ulcerative colitis? Clin. Sci. (Lond.) 1993, 85, 623-627.
86. Motta, J.P.; Flannigan, K.L.; Agbor, T.A.; Beatty, J.K.; Blackler, R.W.; Workentine, M.L.; Da Silva, G.J.; Wang, R.; Buret, A.G.; Wallace, J.L. Hydrogen sulfide protects from colitis and restores intestinal microbiota biofilm and mucus production. Inflamm. Bowel. Dis. 2015, 21, 1006-1017.
87. Goubern, M.; Andriamihaja, M.; Nübel, T.; Blachier, F.; Bouillaud, F. Sulfide, the first inorganic substrate for human cells. FASEB J. 2007, 21, 1699-1706.
88. Blackler, R.W.; Motta, J.P.; Manko, A.; Workentine, M.; Bercik, P.; Surette, M.G.; Wallace, J.L. Hydrogen sulphide protects against NSAID-enteropathy through modulation of bile and the microbiota. Br. J. Pharmacol. 2015, 172, 992-1004.
89. Nagpure, B.V.; Bian, J.S. Interaction of Hydrogen Sulfide with Nitric Oxide in the Cardiovascular System. Oxid. Med. Cell. Longev. 2016, 2016, 6904327.
90. Meng, G.; Ma, Y.; Xie, L.; Ferro, A.; Ji, Y. Emerging role of hydrogen sulfide in hypertension and related cardiovascular diseases. Br. J. Pharmacol. 2015, 172, 5501-5511.
91. Yu, X.H.; Cui, L.B.; Wu, K.; Zheng, X.L.; Cayabyab, F.S.; Chen, Z.W.; Tang, C.K. Hydrogen sulfide as a potent cardiovascular protective agent. Clin. Chim. Acta. 2014, 437, 78-87.
92. Martelli, A.; Testai, L.; Marino, A.; Breschi, M.C.; Da Settimo, F.; Calderone, V. Hydrogen sulphide: Biopharmacological roles in the cardiovascular system and pharmaceutical perspectives. Curr. Med. Chem. 2012, 19, 3325-3336.
93. Ufnal, M.; Sikora, M. The role of brain gaseous transmitters in the regulation of the circulatory system. Curr. Pharm. Biotechnol. 2011, 12, 1322-1333.
94. Sonobe, T.; Haouzi, P. Hydrogen sulfide concentrations in the heart following acute administration: Methodological and physiological conciderations. Am. J. Physiol. Heart Circ. Physiol. 2016.
95. Sikora, M.; Drapala, A.; Ufnal, M. Exogenous hydrogen sulfide causes different hemodynamic effects in normotensive and hypertensive rats via neurogenic mechanisms. Pharmacol. Rep. 2014, 66, 751-758.
96. Szabo, C. Roles of hydrogen sulfide in the pathogenesis of diabetes mellitus and its complications. Antioxid. Redox Signal. 2012, 17, 68-80.
97. Wallace, J.L.; Wang, R. Hydrogen sulfide-based therapeutics: Exploiting a unique but ubiquitous gasotransmitter. Nat. Rev. Drug Discov. 2015, 14, 329-345.
98. 2S interaction are S/N-hybrid species, polysulfides, and nitroxyl. Proc. Natl. Acad. Sci. USA 2015, 112, E4651-E4660.
99. Berenyiova, A.; Grman, M.; Mijuskovic, A.; Stasko, A.; Misak, A.; Nagy, P.; Ondriasova, E.; Cacanyiova, S.; Brezova, V.; Feelisch, M. The reaction products of sulfide and S-nitrosoglutathione are potent vasorelaxants. Nitric Oxide 2015, 46, 123-130.
100. Doel, J.J.; Benjamin, N.; Hector, M.P.; Rogers, M.; Allaker, R.P. Evaluation of bacterial nitrate reduction in the human oral cavity. Eur. J. Oral Sci. 2005, 113, 14-19.
101. Weitzberg, E.; Lundberg, J.O.N. Nonenzymatic nitric oxide production in humans. Nitric Oxide 1998, 2, 1-7.
102. Lundberg, J.O.; Weitzberg, E.; Cole, J.A.; Benjamin, N. Nitrate, bacteria and human health. Nat. Rev. Microbiol. 2004, 2, 593-602.
103. Sobko, T.; Reinders, C.; Norin, E.; Midtvedt, T.; Gustafsson, L.E.; Lundberg, J.O. Gastrointestinal nitric oxide generation in germ-free and conventional rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 287, G993-G997.
104. Sobko, T.; Reinders, C.I.; Jansson, E.Å.; Norin, E.; Midtvedt, T.; Lundberg, J.O. Gastrointestinal bacteria generate nitric oxide from nitrate and nitrite. Nitric. Oxide 2005, 13, 272-278.
105. Silaghi-Dumitrescu, R.; Kim, Y.N.; Viswanathan, R.; Kurtz, D.M., Jr. A flavo-diiron protein from Desulfovibrio vulgaris with oxidase and nitric oxide reductase activities. Evidence for an in vivo nitric oxide scavenging function. Biochemistry 2005, 44, 3572-3579.
106. Stanek, A.; Gadowska-Cicha, A.; Gawron, K.; Wielkoszyński, T.; Adamek, B.; Cieślar, G.; Wiczkowski, A.; Sieroń, A. Role of nitric oxide in physiology and pathology of the gastrointestinal tract. Mini Rev. Med. Chem. 2008, 8, 1549-1560.
107. Hirst, D.G.; Robson, T. Nitric oxide physiology and pathology. Methods Mol. Biol. 2011, 704, 1-13.
108. Lundberg, J.O.; Weitzberg, E. Biology of nitrogen oxides in the gastrointestinal tract. Gut 2013, 62, 616-629.
109. Farrugia, G.; Szurszewski, J.H. Carbon monoxide, hydrogen sulfide, and nitric oxide as signaling molecules in the gastrointestinal tract. Gastroenterology 2014, 147, 303-313.
110. Bohlen, H.G. Nitric oxide and the cardiovascular system. Compr. Physiol. 2015, 5, 803-828.
111. Lei, J.; Vodovotz, Y.; Tzeng, E.; Billiar, T.R. Nitric oxide, a protective molecule in the cardiovascular system. Nitric Oxide 2013, 35, 175-185.
112. Dias, R.G.; Negrão, C.E.; Krieger, M.H. Nitric oxide and the cardiovascular system: Cell activation, vascular reactivity and genetic variant. Arq. Bras. Cardiol. 2011, 96, 68-75.
113. Çengel, A.; Şahinarslan, A. Nitric oxide and cardiovascular system. Anadolu Kardiyol. Derg. 2006, 6, 364-368.
114. Llorens, S.; Jordán, J.; Nava, E. The nitric oxide pathway in the cardiovascular system. J. Physiol. Biochem. 2002, 58, 179-188.
115. Briskey, D.; Tucker, P.S.; Johnson, D.W.; Coombes, J.S. Microbiota and the nitrogen cycle: Implications in the development and progression of CVD and CKD. Nitric Oxide 2016, 57, 64-70.
116. Tiso, M.; Schechter, A.N. Nitrate reduction to nitrite, nitric oxide and ammonia by gut bacteria under physiological conditions. PLoS ONE 2015, 10, e0119712.
117. Regan, J.M.; Harrington, G.W.; Noguera, D.R. Ammonia- and nitrite-oxidizing bacterial communities in a pilot-scale chloraminated drinking water distribution system. Appl. Environ. Microbiol. 2002, 68, 73-81.
118. Heiss, C.; Lauer, T.; Dejam, A.; Kleinbongard, P.; Hamada, S.; Rassaf, T.; Matern, S.; Feelisch, M.; Kelm, M. Plasma nitroso compounds are decreased in patients with endothelial dysfunction. J. Am. Coll. Cardiol. 2006, 47, 573-579.
119. Frea, S.; Bovolo, V.; Pidello, S.; Canavosio, F.G.; Botta, M.; Bergerone, S.; Gaita, F. Clinical and prognostic role of ammonia in advanced decompensated heart failure the cardio-abdominal syndrome? Int. J. Cardiol. 2015, 195, 53-60.
120. Medeiros, W.M.; Carvalho, A.C.; Peres, P.; De Luca, F.A.; Gun, C. The dysfunction of ammonia in heart failure increases with an increase in the intensity of resistance exercise, even with the use of appropriate drug therapy. Eur. J. Prev. Cardiol. 2014, 21, 135-144.
121. Monteiro, M.; Séneca, J.; Magalhães, C. The history of aerobic ammonia oxidizers: From the first discoveries to today. J. Microbiol. 2014, 52, 537-547.
122. Bełtowski, J.; Jamroz, A.; Borkowska, E. Heme oxygenase and carbon monoxide in the physiology and pathology of the cardiovascular system. Postepy. Hig. Med. Dosw. 2004, 58, 83-99.
123. Durante, W.; Johnson, F.K.; Johnson, R.A. Role of carbon monoxide in cardiovascular function. J. Cell. Mol. Med. 2006, 10, 672-686.
124. Maharshak, N.; Ryu, H.S.; Fan, T.J.; Onyiah, J.C.; Schulz, S.; Otterbein, S.L.; Wong, R.; Hansen, J.J.; Otterbein, L.E.; Carroll, I.M.; Plevy, S.E. Escherichia coli heme oxygenase modulates host innate immune responses. Microbiol. Immunol. 2015, 59, 452-465.
125. Onyiah, J.C.; Sheikh, S.Z.; Maharshak, N.; Steinbach, E.C.; Russo, S.M.; Kobayashi, T.; Mackey, L.C.; Hansen, J.J.; Moeser, A.J.; Rawls, J.F.; Borst, L.B.; Otterbein, L.E.; Plevy, S.E. Carbon monoxide and heme oxygenase-1 prevent intestinal inflammation in mice by promoting bacterial clearance. Gastroenterology 2013, 144, 789-798.
126. Garcia, J.L.; Patel, B.K.C.; Ollivier, B. Taxonomic, phylogenetic, and ecological diversity of methanogenic Archaea. Anaerobe 2000, 6, 205-226.
127. Liu, Y.; Whitman, W.B. Metabolic, phylogenetic, and ecological diversity of the methanogenic archaea. Ann. N. Y. Acad. Sci. 2008, 1125, 171-189.
128. Ferry, J.G. Enzymology of one-carbon metabolism in methanogenic pathways. FEMS Microbiol. Rev. 1999, 23, 13-38.
129. 2 reduction vs. acetate fermentation-Isotope evidence. Geochim. Cosmochim. Acta 1986, 50, 693-709.
130. McKay, L.F.; Holbrook, W.P.; Eastwood, M.A. Methane and hydrogen production by human intestinal anaerobic bacteria. Acta Pathol. Microbiol. Immunol. Scand. B 1982, 90, 257-260.
131. Christl, S.U.; Gibson, G.R.; Cummings, J.H. Role of dietary sulphate in the regulation of methanogenesis in the human large intestine. Gut 1992, 33, 1234-1238.
132. Roccarina, D.; Lauritano, E.C.; Gabrielli, M.; Franceschi, F.; Ojetti, V.; Gasbarrini, A. The role of methane in intestinal diseases. Am. J. Gastroenterol. 2010, 105, 1250-1256.
133. Boros, M.; Tuboly, E.; Mészáros, A.; Amann, A. The role of methane in mammalian physiology-Is it a gasotransmitter? J. Breath Res. 2015, 9, 014001.
134. Levitt, M.D.; Furne, J.K.; Kuskowski, M.; Ruddy, J. Stability of human methanogenic flora over 35 years and a review of insights obtained from breath methane measurements. Clin. Gastroenterol. Hepatol. 2006, 4, 123-129.
135. McKay, L.F.; Eastwood, M.A.; Brydon, W.G. Methane excretion in man-A study of breath, flatus, and faeces. Gut 1985, 26, 69-74.
136. Furnari, M.; Savarino, E.; Bruzzone, L.; Moscatelli, A.; Gemignani, L.; Gianini, E.G.; Zentilin, P.; Dulbecco, P.; Savarino, V. Reassessment of the role of methane production between irritable bowel syndrome and functional constipation. J. Gastrointest. Liver Dis. 2012, 21, 157-163.
137. Bratten, J.R.; Spanier, J.; Jones, M.P. Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls. Am. J. Gastroenterol. 2008, 103, 958-963.
138. Lee, K.M.; Paik, C.N.; Chung, W.C.; Yang, J.M.; Choi, M.G. Breath methane positivity is more common and higher in patients with objectively proven delayed transit constipation. Eur. J. Gastroenterol. Hepatol. 2013, 25, 726-732.
139. Pimentel, M.; Lin, H.C.; Enayati, P.; Van Den Burg, B.; Lee, H.R.; Chen, J.H.; Park, S.; Kong, Y.; Conklin, J. Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290, G1089-G1095.
140. Jahng, J.; Jung, I.S.; Choi, E.J.; Conklin, J.L.; Park, H. The effects of methane and hydrogen gases produced by enteric bacteria on ileal motility and colonic transit time. Neurogastroenterol. Motil. 2012, 24, 185-192.
141. Pimentel, M.; Kong, Y.; Park, S. IBS Subjects with Methane on Lactulose Breath Test Have Lower Postprandial Serotonin Levels Than Subjects with Hydrogen. Dig. Dis. Sci. 2004, 49, 84-87.
142. Liu, Y.; Luo, H.S.; Liang, C.B.; Tan, W.; Xia, H.; Xu, W.J. Effects of methane on proximal colon motility of rats and ion channel mechanisms. Zhonghua Yi Xue Za Zhi 2013, 93, 459-463.
143. Mathur, R.; Kim, G.; Morales, W.; Sung, J.; Rooks, E.; Pokkunuri, V.; Weitsman, S.; Barlow, G.M.; Chang, C.; Pimentel, M. Intestinal Methanobrevibacter smithii but not total bacteria is related to diet-induced weight gain in rats. Obesity 2013, 21, 748-754.
144. Mathur, R.; Amichai, M.; Chua, K.S.; Mirocha, J.; Barlow, G.M.; Pimentel, M. Methane and hydrogen positivity on breath test is associated with greater body mass index and body fat. J. Clin. Endocrinol. Metab. 2013, 98, E698-E702.
145. Romano, K.A.; Vivas, E.I.; Amador-Noguez, D.; Rey, F.E. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. mBio 2015, 6, e02481.
146. Koeth, R.A.; Wang, Z.; Levison, B.S.; Buffa, J.A.; Org, E.; Sheehy, B.T.; Britt, E.B.; Fu, X.; Wu, Y.; Li, L.; et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 2013, 19, 576-585.
147. Ufnal, M.; Jazwiec, R.; Dadlez, M.; Drapala, A.; Sikora, M.; Skrzypecki, J. Trimethylamine-N-oxide: A carnitine-derived metabolite that prolongs the hypertensive effect of angiotensin II in rats. Can. J. Cardiol. 2014, 30, 1700-1705.
148. Fukami, K.; Yamagishi, S.I.; Sakai, K.; Kaida, Y.; Yokoro, M.; Ueda, S.; Wada, Y.; Takeuchi, M.; Shimizu, M.; Yamazaki, H.; Okuda, S. Oral L-carnitine supplementation increases trimethylamine-N-oxide but reduces markers of vascular injury in hemodialysis patients. J. Cardiovasc. Pharmacol. 2015, 65, 289-295.
149. Lee, J.H.; Lee, J. Indole as an intercellular signal in microbial communities. FEMS Microbiol. Rev. 2010, 34, 426-444.
150. DeMoss, R.D.; Moser, K. Tryptophanase in diverse bacterial species. J. Bacteriol. 1969, 98, 167-171.
151. Smith, E.A.; Macfarlane, G.T. Formation of phenolic and indolic compounds by anaerobic bacteria in the human large intestine. Microbial. Ecol. 1997, 33, 180-188.
152. Darkoh, C.; Chappell, C.; Gonzales, C.; Okhuysen, P. A rapid and specific method for the detection of indole in complex biological samples. Appl. Environ. Microbiol. 2015, 81, 8093-8097.
153. Kim, J.; Park, W. Indole: A signaling molecule or a mere metabolic byproduct that alters bacterial physiology at a high concentration? J. Microbiol. 2015, 53, 421-428.
154. Atoh, K.; Itoh, H.; Haneda, M. Serum indoxyl sulfate levels in patients with diabetic nephropathy: Relation to renal function. Diabetes Res. Clin. Pract. 2009, 83, 220-226.
155. Yoshikawa, D.; Ishii, H.; Suzuki, S.; Takeshita, K.; Kumagai, S.; Hayashi, M.; Niwa, T.; Izawa, H.; Murohara, T. Plasma Indoxyl sulfate and estimated Glomerular filtration rate-Association with long-term clinical outcome in patients with coronary artery disease. Circ. J. 2014, 78, 2477-2482.
156. Barreto, F.C.; Barreto, D.V.; Liabeuf, S.; Meert, N.; Glorieux, G.; Temmar, M.; Choukroun, G.; Vanholder, R.; Massy, Z.A. Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin. J. Am. Soc. Nephrol. 2009, 4, 1551-1558.
157. Wu, I.W.; Hsu, K.H.; Lee, C.C.; Sun, C.Y.; Hsu, H.J.; Tsai, C.J.; Tzen, C.Y.; Wang, Y.C.; Lin, C.Y.; Wu, M.S. P-cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease. Nephrol. Dial. Transplant. 2011, 26, 938-947.
158. Lekawanvijit, S.; Kompa, A.R.; Manabe, M.; Wang, B.H.; Langham, R.G.; Nishijima, F.; Kelly, D.J.; Krum, H. Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate. PLoS ONE 2012, 7, e41281.
159. Miyazaki, T.; Aoyama, I.; Ise, M.; Seo, H.; Niwa, T. An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-β1 in uraemic rat kidneys. Nephrol. Dial. Transplant. 2000, 15, 1773-1781.
160. Lekawanvijit, S.; Adrahtas, A.; Kelly, D.J.; Kompa, A.R.; Wang, B.H.; Krum, H. Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes? Eur. Heart J. 2010, 31, 1771-1779.
161. Bansal, T.; Alaniz, R.C.; Wood, T.K.; Jayaraman, A. The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation. Proc. Natl. Acad. Sci. USA 2010, 107, 228-233.
162. Zelante, T.; Iannitti, R.; Cunha, C.; DeLuca, A.; Giovannini, G.; Pieraccini, G.; Zecchi, R.; D'Angelo, C.; Massi-Benedetti, C.; Fallarino, F.; Carvalho, A.; Puccetti, P.; Romani, L. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 2013, 39, 372-385.
163. Richardson, A.J.; McKain, N.; Wallace, R.J. Ammonia production by human faecal bacteria, and the enumeration, isolation and characterization of bacteria capable of growth on peptides and amino acids. BMC Microbiol. 2013, 13.
164. Zhang, Q.; Meng, Z. The inotropic effects of ammonia on isolated perfused rat hearts and the mechanisms involved. J. Exp. Biol. 2011, 214, 4048-4054.
165. Perry, B.G.; Pritchard, H.J.; Barnes, M.J. Cerebrovascular, cardiovascular and strength responses to acute ammonia inhalation. Eur. J. Appl. Physiol. 2016, 116, 583-592.